Modulation of Immunologic Response by Preventive Everolimus Application in a Rat CPB Model
Modulation of Immunologic Response by Preventive Everolimus Application in a Rat CPB Model
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Everolimus (EVL) is widely used in solid organ transplantation. It is known to have antiproliferative and immunosuppressive abilities via inhibition of the mTOR pathway. Preventive EVL administration may lower inflammation induced by cardiopulmonary bypass (CPB) and reduce systemic inflammatory response syndrome (SIRS). After oral loading with EVL...
Alternative Titles
Full title
Modulation of Immunologic Response by Preventive Everolimus Application in a Rat CPB Model
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1827930029
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1827930029
Other Identifiers
ISSN
0360-3997
E-ISSN
1573-2576
DOI
10.1007/s10753-016-0412-5
